Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
While rare diseases impact a small population, the cost to society is staggering. It may be in the range of $7.2-$8.6 trillion per year.
Peter Marks Disease Grant Program Pilot Program Rare Pediatric Disease Priority Review Voucher Program Rare Disease Drug Developers Orphan Drug Tax Credit
Source: fortune.com